INGN (Inogen) Other Current Receivables: $0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

INGN Inogen Inc INGN
66 GF Score
Price $6.55
GF Value $6.94
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Inogen Other Current Receivables?

Inogen INGN -5.13% 66 Other Current Receivables is $0.0 Mil as of Mar. 2026. GuruFocus rates INGN with a GF Score™ of 66/100 and a GF Value™ of $6.94 (Fairly Valued). The stock has 3 warning signs investors should review.

Inogen's Other Current Receivables for the quarter that ended in Mar. 2026 was $0.0 Mil.

Inogen's annual Other Current Receivables declined from Dec. 2023 ($0.67 Mil) to Dec. 2024 ($0.00 Mil) but then stayed the same from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($0.00 Mil).

Inogen Other Current Receivables Related Terms

Inogen Other Current Receivables Historical Data

* Premium members only.

The historical data trend for Inogen's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inogen Other Current Receivables Chart

Inogen Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.34 1.63 0.67 0.00 0.00

Inogen Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
INGN
66GF Score
Inogen Inc INGN
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inogen Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of $0.0 Mil mean?
Inogen (INGN) has a Other Current Receivables of $0.0 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Inogen and its competitors.
Is Inogen's Other Current Receivables too high?
Inogen's current Other Current Receivables is $0.0 Mil. Overall, Inogen has a GF Score™ of 66/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Inogen's Other Current Receivables compare to QSI and APYX?
Inogen's Other Current Receivables of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on Inogen and its competitors. Inogen's current Other Current Receivables is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inogen stock overvalued right now?
Based on GuruFocus' analysis, Inogen (INGN) is currently considered Fairly Valued. The stock's GF Value™ is $6.94, compared to a current price of $6.55 — trading 5.7% below its estimated fair value. The current Other Current Receivables is $0.0 Mil. Inogen's overall GF Score™ is 66/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For Inogen (INGN), the current Other Current Receivables is $0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Inogen (INGN) Overvalued in 2026?

Based on GuruFocus' analysis, Inogen stock appears to be undervalued. The current stock price of $6.55 is trading 5.7% below its estimated GF Value™ of $6.94. GuruFocus considers Inogen to be Fairly Valued.

Key valuation signals for INGN:

  • Other Current Receivables: $0.0 Mil
  • GF Value™: $6.94 vs. price of $6.55 (5.7% below fair value)
  • GF Score™: 66/100 with 3 warning signs

No single metric tells the full story. See the INGN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Inogen Business Description

Other Exchanges 6IO:Germany
Address 500 Cummings Center, Suite 2800, Beverly, MA, USA, 01915
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.
66GF Score

Get the complete analysis for INGN

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.55
Price
$6.94
GF Value